Abstract Aim The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic
Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation …

Coarctation of aorta (CoA) is a discrete narrowing in aorta causing obstruction to the flow of
blood. It accounts for 6–8% of all congenital heart diseases. With advances in fetal …

Aortic coarctation accounts for 6% to 8% of all congenital heart disease 1 and occurs with an
incidence of 3 to 4 cases out of 10,000 live births with a male predominance of 2: 1. 2 It is …

Background: Long-term outcome data of stent-implantation for coarctation of the aorta are
limited. We report up to 5 years of postimplant follow-up in patients enrolled into the COAST …

Coarctation of the aorta (CoA) accounts for approximately 5–8% of all congenital heart
defects. Depending on the severity of the CoA and the presence of associated cardiac …

Coarctation of the aorta (CoA) is a common form of congenital heart disease. Adult patients
with CoA may be asymptomatic or may present with hypertension. Over the last few years …

Current management of isolated CoA, localized narrowing of the aortic arch in the absence
of other congenital heart disease, is a success story with improved prenatal diagnosis, high …

BACKGROUND: Covered stent (CS) use for the transcatheter treatment of coarctation of the
aorta (COA) was first described over 20 years ago. The covered Cheatham-platinum stent …

Background Coarctation of the aorta (CoA), a congenital narrowing of the proximal
descending thoracic aorta, is a relatively common form of congenital heart disease …

Objectives This study aimed to describe the safety and efficacy of covered stents in patients
with coarctation of aorta (CoA) for immediate and long-term follow-up. Background Covered …